ADHD and Anxiety: How They Overlap and What Helps

1. Introduction: Why the Two So Often Occur Together

In clinical psychiatry, the coexistence of Attention Deficit Hyperactivity Disorder and anxiety represents one of the most common diagnostic presentations. For a vast number of adults in Ireland, chronic anxiety is the primary symptom that prompts them to seek medical care, often resulting in years of standard treatments for generalised anxiety before anyone identifies the underlying neurodevelopmental differences driving the condition. Many Irish adults have traversed the Health Service Executive mental health services, receiving recurrent diagnoses of general anxiety or panic disorders, while the core executive dysfunction of their ADHD remains completely unaddressed.

Understanding the relationship between these two distinct conditions is essential for achieving long-term psychological recovery and functional stability. This clinical guide analyses the mechanisms through which ADHD generates persistent stress, distinguishes the overlapping cognitive features of both disorders, and explains the secondary development of social anxiety. Furthermore, it details the structural gaps within the Irish public healthcare system, reviews the clinical pharmacology of combined treatments under Irish drug schemes, and outlines how a specialised private assessment provides a comprehensive diagnostic pathway.

2. Do ADHD and Anxiety Often Occur Together?

Clinical surveillance studies consistently establish that approximately 30 to 50 per cent of adults diagnosed with Attention Deficit Hyperactivity Disorder also meet the diagnostic criteria for a coexisting anxiety disorder. While ADHD is a neurodevelopmental condition characterised by lifelong deficits in executive functioning, attention, and impulse control, anxiety disorders are emotional conditions defined by excessive worry, apprehension, and autonomic arousal. Though they possess distinct neurobiological origins and independent genetic profiles, they frequently co-occur, with each condition magnifying the severity and impairment of the other.

When these conditions present simultaneously, the clinical presentation is categorised as a comorbid presentation, which significantly complicates both the diagnostic process and the formulation of an effective treatment plan. Tracing the development of these symptoms is essential, as studies suggest that treating only one condition while ignoring the other generally yields limited results, leaving patients with ongoing functional struggles in their daily lives.

3. Can ADHD Cause Anxiety?

Yes. Attention Deficit Hyperactivity Disorder can actively cause and sustain clinical anxiety, particularly when the underlying neurodevelopmental condition remains undiagnosed or poorly managed. The primary mechanism driving this relationship is the chronic stress generated by daily executive difficulties. Adults with untreated ADHD struggle continuously to regulate their attention, manage their time, initiate boring tasks, and control impulsive decisions, which leads to forgotten commitments, missed deadlines, financial strain, and interpersonal friction.

Over years, these persistent daily struggles activate the body’s autonomic stress response, creating a state of chronic hypervigilance where the individual lives in constant anticipation of their next failure. This chronic stress eventually solidifies into a generalised anxiety pattern. Moreover, the neurobiology of emotional dysregulation exacerbates this vulnerability. Because the ADHD brain experiences emotional reactions with heightened intensity, a minor setback can trigger an overwhelming panic response, further entrenching the anxiety loop.

For a substantial portion of Irish adults, the severe anxiety they have experienced for decades is actually secondary to their undiagnosed ADHD, frequently compounded by rejection sensitivity dysphoria, an extreme emotional sensitivity to perceived criticism or rejection that drives social avoidance and persistent worry. These difficulties are often linked to ADHD emotional dysregulation and rejection sensitivity dysphoria.

4. ADHD or Anxiety: How to Tell the Difference

Distinguishing between primary Attention Deficit Hyperactivity Disorder and primary anxiety represents a major clinical challenge because their symptomatic profiles overlap extensively. Both conditions cause significant concentration difficulties, physical restlessness, and sleep disturbances, yet the underlying cognitive mechanisms and internal experiences are entirely different.

To achieve an accurate differential diagnosis, clinical specialists look past the superficial symptoms to evaluate the cognitive origin of each behaviour. The following comparative analysis details how these overlapping symptoms manifest in each condition.

Because these symptoms present in such similar ways on the surface, self-diagnosis is highly unreliable, making a comprehensive clinical evaluation by a specialist essential.

5. ADHD and Social Anxiety

Social anxiety is exceptionally common in adults with Attention Deficit Hyperactivity Disorder, often developing as a direct secondary consequence of untreated executive deficits. The cognitive difficulties associated with ADHD, such as accidentally interrupting others, forgetting names, missing subtle social cues, or losing track of a conversation, make social interactions highly unpredictable and stressful.

Over time, these repeated social missteps generate a profound fear of being judged, embarrassed, or rejected by peers. This pattern is significantly amplified by rejection sensitivity dysphoria, where the emotional pain of perceived rejection is so intense that individuals develop extreme social avoidance to protect themselves.

This secondary social anxiety is clinically distinct from primary social anxiety disorder. When social anxiety is secondary to ADHD, it often improves dramatically once the underlying neurodevelopmental condition is treated, as the patient gains the executive control needed to navigate social situations successfully. In contrast, primary social anxiety disorder is not rooted in executive dysfunction and requires independent psychotherapeutic interventions.

6. Why ADHD Is Often Missed When Anxiety Is Present

Within the Irish healthcare landscape, adult ADHD is frequently missed because public mental health services are severely overburdened, and anxiety is almost always the presenting complaint that general practitioners focus on treating first. When an individual presents with severe panic and worry, clinical teams typically initiate standard treatments for anxiety, leaving the underlying neurodevelopmental driver completely unrecognised.

This omission is actively driven by ADHD masking, where individuals use anxiety-driven hypervigilance, rigid self-monitoring, and perfectionism to compensate for their executive deficits. While these individuals may appear organised, quiet, and successful on the surface, this constant self-monitoring comes at a massive cognitive cost, eventually leading to profound ADHD burnout.

This masking is particularly common in women with ADHD, who tend to internalise their hyperactive and inattentive struggles, developing secondary anxiety and depression years before anyone identifies the neurodevelopmental condition driving both. Consequently, a proper adult assessment must specifically screen for anxiety as a comorbidity and explore whether the anxiety predates or follows the onset of ADHD symptoms.

7. Does ADHD Medication Help with Anxiety?

For a significant number of patients, treating Attention Deficit Hyperactivity Disorder with appropriate medication leads to an indirect but substantial reduction in clinical anxiety. As executive functioning, task initiation, and cognitive control improve, the daily failures and chronic stress that were generating the anxiety naturally resolve.

However, the pharmacological management of comorbid ADHD and anxiety is highly delicate and requires specialist psychiatric oversight. Stimulant medications, which are the clinical gold standard for ADHD, can occasionally worsen physical anxiety symptoms, such as a rapid heart rate or muscle tension, in sensitive individuals. These stimulants include methylphenidate, commercially prescribed in Ireland under names such as Ritalin and Concerta, as well as Tyvense.

If anxiety worsens on stimulants, non-stimulant options are highly effective alternatives. Atomoxetine, known as Strattera, selectively targets noradrenaline pathways, offering a dual benefit by improving cognitive focus while directly reducing somatic anxiety symptoms. Guanfacine, a non-stimulant alpha-2A agonist, is another valuable option that helps regulate sympathetic nervous system activity.

In some cases where anxiety is a separate, coexisting disorder rather than a byproduct of ADHD, a specialist psychiatrist may recommend combining adult ADHD medication with a selective serotonin reuptake inhibitor. Because of these complex drug interactions, medication decisions must involve a Consultant Psychiatrist rather than general practice management alone.

To help patients manage these ongoing costs, the Irish public health system provides several financial pathways, which are detailed in the following table.

These financial protections ensure that while private psychiatric care requires an initial investment, the long-term maintenance of pharmacological treatment remains structured and affordable.

8. Getting the Right Assessment in Ireland

If an individual recognises both Attention Deficit Hyperactivity Disorder and anxiety in themselves, securing a comprehensive, specialised assessment is the first step toward recovery. The public pathway through the HSE National Clinical Programme for ADHD in Adults is currently plagued by severe staffing constraints.

Prior to 2018, there were zero public adult ADHD services in Ireland. Although the 2021 Model of Care proposed eleven specialised adult teams, only seven are fully in place today, creating a severe geographic lottery where some counties have teams and others have none. Furthermore, general adult psychiatrists trained in Ireland are not required by their training bodies to have ADHD assessment as a core competency, leading many public clinicians to feel unqualified to diagnose the condition, which often results in patients being turned away. This issue is particularly acute at age eighteen, when adolescent CAMHS patients needing to transition to adult care are frequently rejected due to a lack of local adult services.

Accessing a private, Consultant Psychiatrist-led pathway allows patients to bypass these system bottlenecks and secure clinical clarity. At ADHDNow, we do not use the QB test or the CAARS in our adult assessment process. Instead, we use a precise, evidence-based set of validated tools to build a comprehensive clinical profile:

• The Adult ADHD Self-Report Scale v1.1 (ASRS) is a validated screener used to evaluate the frequency and severity of current adult attention deficits and executive challenges.
• The Wender Utah Rating Scale (WURS-25) is used to retrospectively assess childhood symptoms before the age of twelve, satisfying the strict diagnostic requirement of childhood onset.
• The WEISS Symptom Record (WRS II) is a 123-item screening tool that systematically gathers information across nineteen distinct psychiatric domains, including oppositional traits, sleep hygiene, and specific anxiety subscales.
• The Diagnostic Interview for ADHD in Adults (DIVA-5) is a semi-structured DSM-5-based clinical interview that systematically evaluates each of the eighteen ADHD symptoms across both current adult functioning and childhood, ensuring full diagnostic coverage.

Initiating a specialised adult ADHD assessment represents the most effective pathway to move beyond chronic, untreated anxiety and secure the targeted support, executive strategies, and cognitive clarity needed to thrive.

Works Cited

1. Katzman, M.A., Bilkey, T.S., Chokka, P.R., et al. (2017). Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. _BMC Psychiatry_, 17(1), 302. [LINK]
2. D’Agati, E., Curatolo, P. & Mazzone, L. (2019). Comorbidity between ADHD and anxiety disorders across the lifespan. _International Journal of Psychiatry in Clinical Practice_, 23(4), 238–244.[LINK]
3. Fu, X., Wu, W., Wu, Y., et al. (2025). Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. _Frontiers in Psychiatry_, 16. [LINK]
4. Boyd, C., Wrigley, M., Mulligan, A., et al. (2026). An evaluation of the efficacy and acceptability of the National Clinical Programme for ADHD in adults in Ireland. _Irish Journal of Psychological Medicine_, 1–8. [LINK]
5. National Institute for Health and Care Excellence. (2018, updated 2019). _Attention deficit hyperactivity disorder: diagnosis and management (NG87)_.[LINK]
6. Hines, J.L., King, T.S. & Curry, W.J. (2012). The Adult ADHD Self-Report Scale for screening for adult attention deficit-hyperactivity disorder (ADHD). _Journal of the American Board of Family Medicine_, 25(6), 847–853. [LINK]
7. Silverstein, M.J., Faraone, S.V., Alperin, S., et al. (2019). Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. _Journal of Attention Disorders_, 23(10), 1101–1110.[LINK]
8. Alarachi, A., Merrifield, C., Rowa, K., et al. (2024). Are We Measuring ADHD or Anxiety? Examining the Factor Structure and Discriminant Validity of the Adult ADHD Self-Report Scale in an Adult Anxiety Disorder Population. _Assessment_, 31(7), 1508–1524. [LINK]
9. Adler, L.A., Spencer, T., Faraone, S.V., et al. (2006). Validity of pilot Adult ADHD Self-Report Scale (ASRS) to Rate Adult ADHD symptoms. _Annals of Clinical Psychiatry_, 18(3), 145–148. [LINK]
10. Ohnishi, T., Kobayashi, H., Yajima, T., et al. (2019). Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. _Innovations in Clinical Neuroscience_, 16(9–10). [LINK]